| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $53.8M | +1591.6% | +363.6% |
| R&D Expense | $30.8M | -6.1% | -7.4% |
| SG&A Expense | $8.9M | -21.3% | -20.5% |
| Operating Income | $14.1M | +134.3% | +142.8% |
| Pre-tax Income | $15.9M | +140.9% | +154.5% |
| Income Tax | -$10K | -128.6% | -118.5% |
| Net Income | $15.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $58.3M | +48.5% | +9.8% |
| Short-term Investments | $94.5M | -33.2% | -60.7% |
| Current Assets | $163.8M | -13.8% | -45.6% |
| Total Assets | $210.1M | -11.7% | -40.4% |
| Current Liabilities | $18.4M | -53.9% | -50.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$109.2M | — | — |
| Capital Expenditures | $826K | — | — |
| Investing Cash Flow | $94.9M | — | — |
| Financing Cash Flow | $3.1M | — | — |
| Free Cash Flow | -$110.0M | — | — |
| +140.9% |
| +154.5% |
| EPS (Basic) | $0.14 | +140.0% | +151.9% |
| EPS (Diluted) | $0.13 | +137.1% | +148.1% |
| $50.1M |
| -51.3% |
| -59.3% |
| Stockholders' Equity | $160.0M | +18.6% | -30.2% |